SIRT3 Human shRNA Lentiviral Particle (Locus ID 23410)

CAT#: TL309432V

SIRT3 - Human shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control), 0.5 ml each, >10^7 TU/ml.

Product Images

GFP signal was observed under microscope at 48 hours after transduction of TL309432A virus into HEK293 cells. TL309432A virus was prepared using lenti-shRNA TL309432A and TR30037 packaging kit.

• 

  GFP signal was observed under microscope at 48 hours after transduction of TL309432B virus into HEK293 cells. TL309432B virus was prepared using lenti-shRNA TL309432B and TR30037 packaging kit.

• 

  GFP signal was observed under microscope at 48 hours after transduction of [TL309432C] virus into HEK293 cells. [TL309432C] virus was prepared using lenti-shRNA [TL309432C] and TR30037 packaging kit.

• 

  GFP signal was observed under microscope at 48 hours after transduction of [TL309432D] virus into HEK293 cells. [TL309432D] virus was prepared using lenti-shRNA [TL309432D] and TR30037 packaging kit.

Specifications

Product Data

• Locus ID: 23410
• Synonyms: SIR2L3
• Vector: pGFP-C-shLenti
• Format: Lentiviral particles
• RefSeq: NM_001017524, NM_012239, NM_012239.1, NM_012239.2, NM_012239.4, NM_012239.5, NM_001017524.1, NM_001017524.2, BC001042, BM709066, BM973763, NM_001370312, NM_001370314, NM_001370316, NM_001370318, NM_001370319, NM_001370325, NR_163386, NR_163388, NR_163389, NR_163390, NR_163391, NR_163393, NR_163394, NR_163398, NR_163399, NR_163400, NR_163401, NM_001370310, NM_001370315, NM_001370317, NM_001370320, NM_001370321, NM_001370322, NM_001370323, NM_001370324, NR_163387, NR_163392, NR_163395, NR_163396, NR_163397, NR_163402, NM_012239.6
• UniProt ID: Q9NTG7
• Summary: SIRT3 encodes a member of the sirtuin family of class III histone deacetylases, homologs to the yeast Sir2 protein. The encoded protein is found exclusively in mitochondria, where it can eliminate reactive oxygen species, inhibit apoptosis, and prevent the formation of cancer cells. SIRT3 has far-reaching effects on nuclear gene expression, cancer, cardiovascular disease, neuroprotection, aging, and metabolic control. [provided by RefSeq, May 2019]
• shRNA Design: These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service.
• Performance Guaranteed: OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples.
  
  For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred).